The Hyderabad-based pharmaceutical manufacturer said the agreement covers cartridge fill-finish services in India, with no financial terms or additional details disclosed.
Shantha Biologics said it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India. The Hyderabad-based pharmaceutical manufacturer described the deal as part of its focus on high-quality manufacturing execution and its role as a partner to global healthcare companies. It said the collaboration will operate under the parties' contractual framework and in line with applicable quality, compliance, and regulatory requirements. Director Dr. Vishy Chebrol said the agreement reflects confidence in Shantha Biologics' capabilities and its commitment to reliable, high-quality cartridge fill-finish services. No financial terms or further details were disclosed.